Follow the Insight Molecular Diagnostics Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €754k. The latest transaction was disclosed on 6 July 2026 (Retenue fiscale). Among the most active insiders: BROADWOOD PARTNERS, L.P.. All data is free.
25
Insider Decl.
n/a
Thresholds
€5m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
Buys €5mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
35,000 shares0Common Stock, no par valueSEC:0001641172-25-017787:0
25 of 25 declarations
Acerca de Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. es una empresa centrada en el desarrollo de pruebas de diagnóstico molecular. Su objetivo es mejorar la atención médica a través de soluciones innovadoras.